Latest Posts
About This Stock
More About This Stock
Read
Hot Biotech Sector: Mid-Caps Have Both M&A And Pipeline Premiums
Article By:
Rod Raynovich
Wednesday, May 13, 2015 3:26 PM EDT
M&A has been a major driver of bio-pharmaceutical stocks and the buyout of Syngeva by Alexion for $8.4B last week showed that there is a lot of value in pipelines that fit with the acquirer.
In this article: VRX, ARIA, SGEN, ALKS, CLDX, VRTX Also: PCYC, ABBV, MRK, AMGN, GEVA, ACT, SNY, ALNY, FBT, CBST, ALXN